Fenofibrate in Type 2 Diabetes

Summary

Diabetic complications affecting the eyes, kidneys, and nerves are difficult to arrest once in progress. Recent evidence that fenofibrate confers a robust yet unexpected benefit in diabetic retinopathy offers an important translational research opportunity. The investigator's global proteomic study will provide new clues as to how fenofibrate protects vulnerable tissues, and will spur discovery of targets for new therapeutic interventions.

Timeline

Start

2019-02-04

Primary completion

2020-03-04

Completion

2020-03-04

Drugs

Indications